Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln
Feb 6 (Reuters) - Infant Bacterial Therapeutics AB IBTb.ST: Q4 OPERATING INCOME KSEK -20,538* (-37,445) Source text: [ID:] Further company coverage: [IBTb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln